Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 36(2023), 4 vom: 28. Aug., Seite 436-438 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Ajuste posológico de linezolid por interacción con rifampicina en endocarditis infecciosa |
|---|
| Beteiligte Personen: |
Puplà Bartoll, A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 10.07.2023 Date Revised 21.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.37201/req/147.2022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356196100 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356196100 | ||
| 003 | DE-627 | ||
| 005 | 20231226065941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.37201/req/147.2022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356196100 | ||
| 035 | |a (NLM)37116051 | ||
| 035 | |a (PII)pupla28apr2023 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Puplà Bartoll, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis |
| 246 | 3 | 3 | |a Ajuste posológico de linezolid por interacción con rifampicina en endocarditis infecciosa |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.07.2023 | ||
| 500 | |a Date Revised 21.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a CYP2J2 | |
| 650 | 4 | |a Endocarditis | |
| 650 | 4 | |a Linezolid | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Rifampicin | |
| 650 | 7 | |a Linezolid |2 NLM | |
| 650 | 7 | |a ISQ9I6J12J |2 NLM | |
| 650 | 7 | |a Rifampin |2 NLM | |
| 650 | 7 | |a VJT6J7R4TR |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Bellés Medall, M D |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez Catalán, I E |e verfasserin |4 aut | |
| 700 | 1 | |a Roig Martí, C |e verfasserin |4 aut | |
| 700 | 1 | |a Bodega Azuara, J |e verfasserin |4 aut | |
| 700 | 1 | |a Gil Candel, M |e verfasserin |4 aut | |
| 700 | 1 | |a Esteve López, V |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrando Piqueres, R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia |d 1997 |g 36(2023), 4 vom: 28. Aug., Seite 436-438 |w (DE-627)NLM090649028 |x 1988-9518 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2023 |g number:4 |g day:28 |g month:08 |g pages:436-438 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.37201/req/147.2022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2023 |e 4 |b 28 |c 08 |h 436-438 | ||